secwatch.observer — SEC 8-K summary
======================================

Issuer:     TENAX THERAPEUTICS, INC. (TENX)
CIK:        0000034956
Form:       8-K
Filed at:   2024-02-23T23:59:59+00:00
Accession:  0001654954-24-002134
Event type: regulatory
Sentiment:  positive
Materiality: 0.60
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Tenax Therapeutics regains Nasdaq minimum float compliance; deficiency closed
-----------------------------------------------------------------------------

- Received Nasdaq notice on Feb 22, 2024 confirming over 500,000 publicly held shares.
- Regained compliance with Nasdaq Listing Rule 5550(a)(4) regarding minimum public float.
- Prior deficiency notice on Jan 11, 2024 has been resolved and matter closed.
- Company remains listed on Nasdaq Capital Market.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/34956/000165495424002134/0001654954-24-002134-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/34956/000165495424002134/tenx_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-24-002134

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer